Gater, A., Reaney, M., Findley, A., Brun-Strang, C., Burrows, K., Nguyên-Pascal, M., & Roborel de Climens, A. (2020). Development and First Use of the Patient's Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit-Harm of Drugs Received During Clinical Studies. Drug Safety, 43(2), 119. https://doi.org/10.1007/s40264-019-00877-4
Chicago Style (17th ed.) CitationGater, Adam, Matthew Reaney, Amy Findley, Catherine Brun-Strang, Kate Burrows, My-Liên Nguyên-Pascal, and Aude Roborel de Climens. "Development and First Use of the Patient's Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit-Harm of Drugs Received During Clinical Studies." Drug Safety 43, no. 2 (2020): 119. https://doi.org/10.1007/s40264-019-00877-4.
MLA (9th ed.) CitationGater, Adam, et al. "Development and First Use of the Patient's Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit-Harm of Drugs Received During Clinical Studies." Drug Safety, vol. 43, no. 2, 2020, p. 119, https://doi.org/10.1007/s40264-019-00877-4.